Epigallocatechin-3-gallate Alleviates Ethanol-Induced Endothelia Cells Injury Partly through Alteration of NF-κB Translocation and Activation of the Nrf2 Signaling Pathway-Reference-Cited by-同舟云学术

Epigallocatechin-3-gallate Alleviates Ethanol-Induced Endothelia Cells Injury Partly through Alteration of NF-κB Translocation and Activation of the Nrf2 Signaling Pathway

Published:2024-07-05 Issue:7 Volume:47 Page:1248-1254
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Xu Jie¹²,Xu Shouzhu¹,Luo Jiayin¹,Zhang Shihao¹,Wu Dongdong¹,Yang Qifan¹,Fang Rourou¹,Shi Chuandao¹,Liu Qiling¹,Zhao Jing³

Affiliation:

1. Department of Public Health, Shaanxi University of Chinese Medicine

2. College of Life Sciences, Northwest University

3. Shaanxi Key Laboratory of Acupuncture & Medicine, Shaanxi University of Chinese Medicine

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/bpb/47/7/47_b23-00773/_pdf

Reference41 articles.

1. 1) Amundsen MS, Kirkeby TM, Giri S, Koju R, Krishna SS, Ystgaard B, Solligard E, Risnes K. Non-communicable diseases at a regional hospital in Nepal: findings of a high burden of alcohol-related disease. Alcohol, 57, 9–14 (2016).

2. 2) Parry CD, Patra J, Rehm J. Alcohol consumption and non-communicable diseases: epidemiology and policy implications. Addiction, 106, 1718–1724 (2011).

3. 3) Fan Z, Yun J, Yu S, Yang Q, Song L. Alcohol consumption can be a “double-edged sword” for chronic kidney disease patients. Med. Sci. Monit., 25, 7059–7072 (2019).

4. 4) Yamada K, Ueda K, Shirakawa H, Giriwono PE, Honda S, Sakurai H, Komai M. The effect of liver hydrolysate on chronic ethanol-induced hepatic injury in normal rats. Biol. Pharm. Bull., 43, 554–557 (2020).

5. 5) Massaro M, Scoditti E, Carluccio MA, De Caterina R. Alcohol and atherosclerosis: a double edged sword. Vascul. Pharmacol., 57, 65–68 (2012).